Trusted Voices
Thanking Rod MacKenzie for his countless contributions to Pfizer, the industry and patients around the globe. After 35 years of outstanding service to Pfizer, Rod MacKenzie, PhD, Chief Development Officer and Executive Vice President, has informed me of his intent to retire early next year. This is a bittersweet time for me and for all those colleagues who have worked with Rod over the course of his career. I will miss working with my friend, but I am excited to see the wonderful things he...
Real People
Payal Sahni did not expect – or plan -- to work for a multi-national corporation. In fact, when a college professor asked her if she’d ever considered a corporate career, she replied, “absolutely not.” At the time, Sahni was pursuing a graduate degree in psychology. She believed corporate America was “stuffy” and “political,” and “wanted nothing to do with it,” she says. But she told her professor she was open to exploring and applied for a summer internship at Pfizer, a pharmaceutical and...
Living & Wellbeing
A medical diagnosis can raise countless questions and concerns. One way that patients can empower themselves with knowledge and surround themselves with support is by finding an advocacy group that focuses on that particular condition or disease and the challenges that may surround it. “The work of patient advocacy groups is very important to provide education and support; sometimes these groups have social workers on staff that can provide that psychosocial support to people, and and advocate...
Living & Wellbeing
The phrase “knowledge is power” rings true in healthcare encounters as much as it does in day-to-day life. “Patient education is important so that patients can make informed decisions in their care and treatment plans,” says Mike Zincone, Senior Director of Patient Advocacy at Pfizer. Research has shown that patient education significantly improves adherence with taking prescribed medications.1 One of the big challenges when it comes to patient education, says Zincone, is determining where to...
The Antigen is an eight-part audio-documentary style podcast about the scientific, cultural, and political elements of vaccination. We start with the basic science, review vaccine history, explore the many facets of their global impact, and the public sentiment about vaccines around the world. Hear from leading experts about the past, present, and future of this important innovation, as well as people whose families have been impacted by vaccine-preventable diseases. Host: Jasmeen Agosti M.D...
Purpose & Ideals
While it’s easy to recognize the economic and social benefits that suppliers and their communities receive by doing business with a global biopharmaceutical company such as Pfizer, the benefits are far more mutual than they may seem. Applying innovative perspectives gained from working with suppliers that bring diversity, Pfizer is better able to improve patient care through these connections to a more inclusive group of communities, thus improving health for all. One way Pfizer has worked to...
From 2010 to July 2021, ClinicalTrials.gov reports that the number of registered clinical trials more than tripled, growing from 100,208 to 384,288 and counting.1 The race for a COVID-19 vaccine made clinical trials headline news in 2020 and 2021, with thousands of people worldwide volunteering to take part in vaccine studies. Still, for some, the details of what clinical trials do and how they work may not be clear. Judy Sewards, Head of Clinical Trial Experience at Pfizer, offers some...
When you think of a statistician, you may picture a math whiz hastily scrawling formulas on a white board in the halls of academia or the trading floors of finance. But statisticians—specifically, biostatisticians—play a critical role in discovering and developing new medicines. “If we want to get the most from the data, analysis, and experiment, more often than not, it requires early partnership between scientists and biostatisticians in the design and analysis plan,” says Vice President, Head...
Programs & Initiatives
It was December 15, 2020 when Melissa French got the message: Pfizer needed large quantities of something called a cationic lipid that was critical to the COVID-19 vaccine. “This isn’t an everyday lipid that's readily available,” says French, who is a Project Manager with Pfizer Global Supply, and handles lipid production at a facility in Kalamazoo, Michigan. She was being asked to lead a team in producing large amounts of this important raw material.The call wasn’t a complete surprise. A number...
Programs & Initiatives
On a Sunday afternoon in May of 2020, Amy Genest’s phone rang. She recognized the number immediately and excused herself from her young daughters and her husband to take the work call. On the line, a colleague at Pfizer told her she needed help in securing contract manufacturing organizations (CMOs) to assist with vaccine production, when—and if—Pfizer and BioNTech were authorized to manufacture a COVID-19 vaccine.That task was nothing new for Genest, who at the time served as New Products Lead...
Programs & Initiatives
On March 11, 2020 the World Health Organization declared COVID-19 a pandemic.1 Just six days later, on March 17, Pfizer signed a letter of intent with BioNTech to co-develop a potential COVID-19 vaccine.2 In those early days, it was unclear how this new virus was transmitted, or how long it would last. But as deaths around the world mounted and life as we knew it drastically changed, one thing became apparent: the virus was spreading rapidly, and the race for a vaccine was underway.3BioNTech, a...
Living & Wellbeing
Annlouise Assaf’s grandmother didn’t speak much English when she left Lebanon for the United States in the early 1900s. The language barrier forced Assaf and her siblings — who were just kids — to stand in as the chief interpreters during doctors’ appointments. As her grandma’s health hung in the balance, Assaf soon found herself juggling much more than two dialects. “The doctor would ask us all these questions,” recalls Assaf. “But first, we had to understand what the doctor was asking us.” T...
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.